# OnCo record therap (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/therap/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "therap", "NCT03392428" ;
  schema:name "TheraP (ANZUP 1603)"@en ;
  schema:description "The randomised trial that first pitted a radioligand against chemotherapy and won on response, with fewer side effects."@en ;
  schema:url <https://onco.cc/trials/therap/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03392428> ;
  onco:status "positive" ;
  onco:phase "2" ;
  schema:startDate "2018-01-29" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/psma-pet/> ;
  onco:drugs <https://onco.cc/drugs/pluvicto/>, <https://onco.cc/drugs/cabazitaxel/> ;
  onco:companies <https://onco.cc/companies/anzup/> ;
  onco:institutions <https://onco.cc/institutions/peter-mac/> ;
  onco:terms <https://onco.cc/terms/psa50/>, <https://onco.cc/terms/prostate-crpc-sequencing/> ;
  onco:trials <https://onco.cc/trials/vision/>, <https://onco.cc/trials/card/>, <https://onco.cc/trials/psmafore/> ;
  onco:people <https://onco.cc/people/hofman-michael/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-therap-lancet-2021/>, <https://onco.cc/key-papers/paper-therap-lancet-oncol-2024-update/> .